Company Filing History:
5 out of 153 
1 out of 21 
Years Active: 2003-2017
Title: Innovations and Contributions of Nicholas Chiorazzi
Introduction
Nicholas Chiorazzi is a notable inventor based in Tenafly, NJ (US), recognized for his significant contributions to the field of medical research. He holds a total of 6 patents, showcasing his innovative approach to addressing complex medical challenges.
Latest Patents
Chiorazzi's latest patents include groundbreaking methods and compositions for the diagnosis and treatment of B cell chronic lymphocytic leukemia (B-CLL). One of his inventions provides an anti-idiotype antibody that binds to the antigen-binding region of an antibody encoded by specific antibody genes. This advancement has the potential to enhance treatment options for patients suffering from this condition. Another significant patent discloses a method for determining the prognosis and probable clinical course of a subject diagnosed with B-CLL. This method involves comparing CD38 expression in a biological sample from the subject to a baseline level, which can indicate the aggressiveness of the disease.
Career Highlights
Throughout his career, Nicholas Chiorazzi has worked with esteemed organizations such as the Feinstein Institute for Medical Research and North Shore-LIJ Research Institute. His work in these institutions has allowed him to contribute to vital research in the field of chronic lymphocytic leukemia.
Collaborations
Chiorazzi has collaborated with notable colleagues, including Rajendra N Damle and Tarun Wasil, further enhancing the impact of his research and innovations.
Conclusion
Nicholas Chiorazzi's contributions to medical research, particularly in the area of B cell chronic lymphocytic leukemia, highlight his role as an influential inventor. His patents and collaborations reflect a commitment to advancing healthcare solutions.